Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rachel Youngblood

Physician Assistant Macon, GA Physician Assistant

NPI 1033405477 CMS profile 10925981

840 Pine St Ste 750, Macon, GA 31201

Open in the dashboard

General payments

$11,065

514 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rachel Youngblood of Macon, GA is reported in the CMS Open Payments database as having received $11,065 across 514 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $525 23
2024 General $2,503 116
2023 General $3,399 146
2022 General $2,824 134
2021 General $1,814 95

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rachel Youngblood
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Rachel Youngblood were reported at $525. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Rachel Youngblood Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,814 $132 $37–$438 $132
2022 $2,824 $155 $48–$522 $149
2023 $3,399 $167 $52–$557 $160
2024 $2,503 $178 $55–$600 $164
2025 $525 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novartis Pharmaceuticals Corporation $852 36 payments
  2. Merck Sharp & Dohme Corporation $815 39 payments
  3. Seattle Genetics, Inc. $597 26 payments
  4. Daiichi Sankyo Inc. $537 21 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $533 16 payments
  6. Amgen Inc. $493 28 payments
  7. Pfizer Inc. $442 26 payments
  8. AbbVie, Inc. $396 15 payments
  9. Astellas Pharma US Inc $378 18 payments
  10. Incyte Corporation $360 17 payments
  11. Other $5,662 272 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,034 501 payments
  2. Education $1,031 13 payments
Products named General payments · program years 2021–2025
  1. KEYTRUDA $786 37 payments
  2. KISQALI $521 19 payments
  3. LIBTAYO $388 16 payments
  4. PIQRAY $332 11 payments
  5. Lenvima $331 15 payments
  6. VENCLEXTA $292 9 payments
  7. XTANDI $273 16 payments
  8. TUKYSA $267 17 payments
  9. INJECTAFER $266 12 payments
  10. NINLARO $258 9 payments
  11. Other $9,194 490 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

502

Median for Physician Assistant: 241

Drug cost

$849,857

Median for Physician Assistant: $4,110

Branded share of claims

19.5%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Revlimid Lenalidomide Brand 23 $429,361
Imbruvica Ibrutinib Brand 14 $228,647
Xtandi Enzalutamide Brand 12 $171,248
Eliquis Apixaban Brand 25 $14,326
Letrozole Generic 41 $1,044
Hydroxyurea Generic 18 $799
Anastrozole Generic 34 $764
Dexamethasone Generic 69 $744
Pregabalin Generic 16 $593
Potassium Chloride Generic 40 $529

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$17,075

Medicare's payments for the services billed

Medicare patients

181

Average age 73

Services billed

292

100 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 59%
Cancer 54%
Diabetes 49%
Arthritis 46%
Ischemic heart disease 44%
Depression 39%
Heart failure 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 66 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KEYTRUDA
$202 — —
IMBRUVICA
$124 14 —
Lenvima
$116 — —
CABOMETYX
$95 — —
LIBTAYO
$84 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 66 with Patron

Records

514 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record